Phosphoserine
|
Basic information |
| Metabolite name | Phosphoserine |
 | HMDB0000272 |
 |
C01005 |
 |
68841 |
| Synonyms | 3-phospho-L-serine |
| No. of studies | 4 |
|
Basic information |
| Metabolite name | Phosphoserine |
| HMDB0000272 |
|
C01005 |
|
68841 |
| Synonyms | 3-phospho-L-serine |
| No. of studies | 4 |
|
Relationship between Phosphoserine and depression (count: 4) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M001 | Type1 | depressed group vs. control group | Plasma | Human | Down |
| Study M181 | Type3 | venlafaxine group vs. control group | Prefrontal cortex | Sprague-Dawley rat | Down |
| Study M882 | Type1 | CUMS group vs. control group | Hippocampus | Sprague-Dawley rat | Down |
| Study M940 | Type1 | CUMS group vs. control group | Cerebral cortex | Sprague-Dawley rat | Up |
| Study M940 | Type2 | CUMS + Chaihu group vs. CUMS group | Cerebral cortex | Sprague-Dawley rat | Down |
| Study M940 | Type2 | CUMS + Chaihu-Baishao herb pair group vs. CUMS group | Cerebral cortex | Sprague-Dawley rat | Down |